Ethical Dilemma with Stakeholders
You're the CEO of a pharmaceutical company. Your best-selling drug ($2B annual revenue, used by 4 million patients for chronic pain) has…
I would treat this as a credible, urgent safety signal, not as a finding that can wait six months for a completed regulatory submission. The estimate—liver failure in roughly 1 in 8,000 patients over five years—needs validation, but the outcome is severe and the current warning omits it.Read the full answer
Immediate Priorities Prioritize patient safety by initiating monitoring and reporting preparations, while assessing full data to inform board and regulators. Ethically and legally, liver failure qualifies as a serious adverse event requiring FDA expedited reporting within 15 days of awareness, as delays have led to…Read the full answer